DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Olfactory transduction	R-HSA-9751605	map04740	parbendazole	9642	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	parbendazole	9642	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	parbendazole	9642	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	parbendazole	9642	drug-path
Apoptosis	R-HSA-109581	map04210	parbendazole	9642	drug-path
Cardiac muscle contraction	R-HSA-397014	map04260	parbendazole	9642	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	parbendazole	9642	drug-path
ABC transporters	R-HSA-1369007	map02010	isoxsuprine	3783	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	isoxsuprine	3783	drug-path
Gap junction	R-HSA-190861	map04540	oxetacaine	4621	drug-path
Insulin signaling pathway	R-HSA-74752	map04910	oxetacaine	4621	drug-path
Huntington's disease	R-HSA-1643685	0	oxetacaine	4621	drug-path
Olfactory transduction	R-HSA-9751605	map04740	oxetacaine	4621	drug-path
Parkinson's disease	R-HSA-1643685	0	oxetacaine	4621	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	oxetacaine	4621	drug-path
Olfactory transduction	R-HSA-9751605	map04740	dicycloverine	3042	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	dicycloverine	3042	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	dicycloverine	3042	drug-path
Focal adhesion	R-HSA-354113	map04510	dicycloverine	3042	drug-path
Shigellosis	0	map05131	hexamethonium bromide	5938	drug-path